49 related articles for article (PubMed ID: 33710019)
1. Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia.
Kapetanovic S; Giganti MJ; Abzug MJ; Lindsey JC; Sirois PA; Montepiedra G; Canniff J; Agwu A; Boivin MJ; Weinberg A;
AIDS; 2021 Jul; 35(9):1375-1384. PubMed ID: 33710019
[TBL] [Abstract][Full Text] [Related]
2. Correction to: Association of Social Needs with Uncontrolled Viremia in People with HIV.
Hanna DB; Felsen UR; Anastos K; Bauman LJ; Fiori KP; Ginsberg MS; Watnick D; Chambers EC
AIDS Behav; 2022 Nov; 26(11):3746. PubMed ID: 35704126
[No Abstract] [Full Text] [Related]
3. Discovering translational biomarkers in neurodevelopmental disorders.
Sahin M; Jones SR; Sweeney JA; Berry-Kravis E; Connors BW; Ewen JB; Hartman AL; Levin AR; Potter WZ; Mamounas LA
Nat Rev Drug Discov; 2018 Dec; ():. PubMed ID: 30936503
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Efficacy of ALVAC-HIV and Bivalent Subtype C gp120-MF59 in Adults.
Gray GE; Bekker LG; Laher F; Malahleha M; Allen M; Moodie Z; Grunenberg N; Huang Y; Grove D; Prigmore B; Kee JJ; Benkeser D; Hural J; Innes C; Lazarus E; Meintjes G; Naicker N; Kalonji D; Nchabeleng M; Sebe M; Singh N; Kotze P; Kassim S; Dubula T; Naicker V; Brumskine W; Ncayiya CN; Ward AM; Garrett N; Kistnasami G; Gaffoor Z; Selepe P; Makhoba PB; Mathebula MP; Mda P; Adonis T; Mapetla KS; Modibedi B; Philip T; Kobane G; Bentley C; Ramirez S; Takuva S; Jones M; Sikhosana M; Atujuna M; Andrasik M; Hejazi NS; Puren A; Wiesner L; Phogat S; Diaz Granados C; Koutsoukos M; Van Der Meeren O; Barnett SW; Kanesa-Thasan N; Kublin JG; McElrath MJ; Gilbert PB; Janes H; Corey L;
N Engl J Med; 2021 Mar; 384(12):1089-1100. PubMed ID: 33761206
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir, pregnancy and renal function changes in pregnant women living with HIV.
Thimm MA; Eke AC
AIDS; 2021 Jul; 35(8):1319-1320. PubMed ID: 33710027
[TBL] [Abstract][Full Text] [Related]
6. Persistent Immune Activation in Human Immunodeficiency Virus-Infected Pregnant Women Starting Combination Antiretroviral Therapy After Conception.
Lohman-Payne B; Koster J; Gabriel B; Chilengi R; Forman LS; Heeren T; Duffy CR; Herlihy J; Crimaldi S; Gill C; Chavuma R; Mwananyanda L; Thea DM
J Infect Dis; 2022 Apr; 225(7):1162-1167. PubMed ID: 33780543
[TBL] [Abstract][Full Text] [Related]
7. Predicting HIV Incidence in the SEARCH Trial: A Mathematical Modeling Study.
Jewell BL; Balzer LB; Clark TD; Charlebois ED; Kwarisiima D; Kamya MR; Havlir DV; Petersen ML; Bershteyn A
J Acquir Immune Defic Syndr; 2021 Aug; 87(4):1024-1031. PubMed ID: 33770065
[TBL] [Abstract][Full Text] [Related]
8. Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis.
Cutrell AG; Schapiro JM; Perno CF; Kuritzkes DR; Quercia R; Patel P; Polli JW; Dorey D; Wang Y; Wu S; Van Eygen V; Crauwels H; Ford SL; Baker M; Talarico CL; Clair MS; Jeffrey J; White CT; Vanveggel S; Vandermeulen K; Margolis DA; Aboud M; Spreen WR; van Lunzen J
AIDS; 2021 Jul; 35(9):1333-1342. PubMed ID: 33730748
[TBL] [Abstract][Full Text] [Related]
9. Progress toward HIV elimination goals: trends in and projections of annual HIV testing and condom use in Africa.
Nguyen PT; Gilmour S; Le PM; Onishi K; Kato K; Nguyen HV
AIDS; 2021 Jul; 35(8):1253-1262. PubMed ID: 33730746
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of residual immune activation in HIV-1-infected human lymphoid tissue ex vivo.
Mercurio V; Fitzgerald W; Vanpouille C; Molodtsov I; Margolis L
AIDS; 2021 Jul; 35(8):1179-1190. PubMed ID: 33710022
[TBL] [Abstract][Full Text] [Related]
11. Eliminating postnatal HIV transmission in high incidence areas: need for complementary biomedical interventions.
Van de Perre P; Goga A; Ngandu N; Nagot N; Moodley D; King R; Molès JP; Mosqueira B; Chirinda W; Scarlatti G; Tylleskär T; Dabis F; Gray G
Lancet; 2021 Apr; 397(10281):1316-1324. PubMed ID: 33812490
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
Lockman S; Brummel SS; Ziemba L; Stranix-Chibanda L; McCarthy K; Coletti A; Jean-Philippe P; Johnston B; Krotje C; Fairlie L; Hoffman RM; Sax PE; Moyo S; Chakhtoura N; Stringer JS; Masheto G; Korutaro V; Cassim H; Mmbaga BT; João E; Hanley S; Purdue L; Holmes LB; Momper JD; Shapiro RL; Thoofer NK; Rooney JF; Frenkel LM; Amico KR; Chinula L; Currier J;
Lancet; 2021 Apr; 397(10281):1276-1292. PubMed ID: 33812487
[TBL] [Abstract][Full Text] [Related]
13. Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study.
Orkin C; Oka S; Philibert P; Brinson C; Bassa A; Gusev D; Degen O; García JG; Morell EB; Tan DHS; D'Amico R; Dorey D; Griffith S; Thiagarajah S; St Clair M; Van Solingen-Ristea R; Crauwels H; Ford SL; Patel P; Chounta V; Vanveggel S; Cutrell A; Van Eygen V; Vandermeulen K; Margolis DA; Smith KY; Spreen WR
Lancet HIV; 2021 Apr; 8(4):e185-e196. PubMed ID: 33794181
[TBL] [Abstract][Full Text] [Related]
14. Optimizing HIV retesting during pregnancy and postpartum in four countries: a cost-effectiveness analysis.
Meisner J; Roberts DA; Rodriguez P; Sharma M; Newman Owiredu M; Gomez B; de Mello MB; Bobrik A; Vodianyk A; Storey A; Githuka G; Chidarikire T; Barnabas R; Farid S; Essajee S; Jamil MS; Baggaley R; Johnson C; Drake AL
J Int AIDS Soc; 2021 Apr; 24(4):e25686. PubMed ID: 33787064
[TBL] [Abstract][Full Text] [Related]
15. Mother-to-child transmission of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in HIV-infected pregnant women in South Africa.
Peters RP; Feucht UD; de Vos L; Ngwepe P; McIntyre JA; Klausner JD; Medina-Marino A
Int J STD AIDS; 2021 Aug; 32(9):799-805. PubMed ID: 33769901
[TBL] [Abstract][Full Text] [Related]
16. Routine asymptomatic testing strategies for airline travel during the COVID-19 pandemic: a simulation study.
Kiang MV; Chin ET; Huynh BQ; Chapman LAC; Rodríguez-Barraquer I; Greenhouse B; Rutherford GW; Bibbins-Domingo K; Havlir D; Basu S; Lo NC
Lancet Infect Dis; 2021 Jul; 21(7):929-938. PubMed ID: 33765417
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial.
Courlet P; Barbieux C; Sculier D; Wandeler G; Stoeckle M; Bernasconi E; Braun D; Vernazza P; Cavassini M; Marinosci A; Smit M; Günthard HF; Schmid P; Limacher A; Guidi M; Alves Saldanha S; Decosterd LA; Calmy A
Br J Clin Pharmacol; 2021 Nov; 87(11):4455-4460. PubMed ID: 33764567
[TBL] [Abstract][Full Text] [Related]
18. In-utero exposure to zidovudine-containing antiretroviral therapy and clonal hematopoiesis in HIV-exposed uninfected newborns.
Lin SH; Wang Y; Hartley SW; Karyadi DM; Lee OW; Zhu B; Zhou W; Brown DW; Beilstein-Wedel E; Hazra R; Kacanek D; Chadwick EG; Marsit CJ; Poirier MC; Brummel SS; Chanock SJ; Engels EA; Machiela MJ;
AIDS; 2021 Aug; 35(10):1525-1535. PubMed ID: 33756513
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
Sapena V; Enea M; Torres F; Celsa C; Rios J; Rizzo GEM; Nahon P; Mariño Z; Tateishi R; Minami T; Sangiovanni A; Forns X; Toyoda H; Brillanti S; Conti F; Degasperi E; Yu ML; Tsai PC; Jean K; El Kassas M; Shousha HI; Omar A; Zavaglia C; Nagata H; Nakagawa M; Asahina Y; Singal AG; Murphy C; Kohla M; Masetti C; Dufour JF; Merchante N; Cavalletto L; Chemello LL; Pol S; Crespo J; Calleja JL; Villani R; Serviddio G; Zanetto A; Shalaby S; Russo FP; Bielen R; Trevisani F; Cammà C; Bruix J; Cabibbo G; Reig M
Gut; 2022 Mar; 71(3):593-604. PubMed ID: 33741640
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083.
Marzinke MA; Grinsztejn B; Fogel JM; Piwowar-Manning E; Li M; Weng L; McCauley M; Cummings V; Ahmed S; Haines CD; Bushman LR; Petropoulos C; Persaud D; Adeyeye A; Kofron R; Rinehart A; St Clair M; Rooney JF; Pryluka D; Coelho L; Gaur A; Middelkoop K; Phanuphak N; Cohen MS; Hendrix CW; Anderson P; Hanscom B; Donnell D; Landovitz RJ; Eshleman SH
J Infect Dis; 2021 Nov; 224(9):1581-1592. PubMed ID: 33740057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
